Loading...
Derniers dépôts
-
Simon Décary, Maarten de Wit, Florian Naye, Jennifer Barton, Liana Fraenkel, et al.. Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials. Seminars in Arthritis and Rheumatism, 2024, 65, pp.152381. ⟨10.1016/j.semarthrit.2024.152381⟩. ⟨hal-04564112⟩
-
Philip Mease, Arthur Kavanaugh, Dafna Gladman, Oliver Fitzgerald, Enrique R. Soriano, et al.. Disease Control with Upadacitinib in Patients with Psoriatic Arthritis: A Post Hoc Analysis of the Randomized, Placebo-Controlled SELECT-PsA 1 and 2 Phase 3 Trials. Rheumatology and Therapy, 2022, 9 (4), pp.1181--1191. ⟨10.1007/s40744-022-00449-6⟩. ⟨hal-03896058⟩
-
Pedro M Machado, Saskia Lawson-Tovey, Anja Strangfeld, Elsa F Mateus, Kimme L Hyrich, et al.. Safety of Vaccination against SARS-CoV-2 in People with Rheumatic and Musculoskeletal Diseases: Results from the EULAR Coronavirus Vaccine (COVAX) Physician-Reported Registry. Annals of the Rheumatic Diseases, 2022, 81 (5), pp.695--709. ⟨10.1136/annrheumdis-2021-221490⟩. ⟨hal-03896047⟩
-
Josef S Smolen, Robert B M Landewé, Johannes W J Bijlsma, Gerd R Burmester, Maxime Dougados, et al.. EULAR Recommendations for the Management of Rheumatoid Arthritis with Synthetic and Biological Disease-Modifying Antirheumatic Drugs: 2019 Update. Annals of the Rheumatic Diseases, 2020, 79 (6), pp.685--699. ⟨10.1136/annrheumdis-2019-216655⟩. ⟨hal-03895158⟩
-
Robert B M Landewé, Féline P B Kroon, Alessia Alunno, Aurélie Najm, Johannes Wj Bijlsma, et al.. EULAR Recommendations for the Management and Vaccination of People with Rheumatic and Musculoskeletal Diseases in the Context of SARS-CoV-2: The November 2021 Update. Annals of the Rheumatic Diseases, 2022, pp.annrheumdis-2021-222006. ⟨10.1136/annrheumdis-2021-222006⟩. ⟨hal-03894183⟩
-
Pil Højgaard, Louise Klokker, Ana-Maria Orbai, Kim Holmsted, Else M. Bartels, et al.. A Systematic Review of Measurement Properties of Patient Reported Outcome Measures in Psoriatic Arthritis: A GRAPPA-OMERACT Initiative. Seminars in Arthritis and Rheumatism, 2018, 47 (5), pp.654--665. ⟨10.1016/j.semarthrit.2017.09.002⟩. ⟨hal-03888153⟩
-
Alessia Alunno, Paul Studenic, Elena Nikiphorou, Petra Balážová, Linda Van Nieuwkoop, et al.. Person-Focused Care for Young People with Rheumatic and Musculoskeletal Diseases: Young Rheumatologists' and EULAR Young PARE Perspectives. RMD Open : Rheumatic & Musculoskeletal Diseases, 2017, 3 (2), pp.e000514. ⟨10.1136/rmdopen-2017-000514⟩. ⟨hal-03892120⟩
-
Sofia Ramiro, Josef S Smolen, Robert Landewé, Désirée van Der Heijde, Laure Gossec. How Are Enthesitis, Dactylitis and Nail Involvement Measured and Reported in Recent Clinical Trials of Psoriatic Arthritis? A Systematic Literature Review. Annals of the Rheumatic Diseases, 2018, 77 (5), pp.782--783. ⟨10.1136/annrheumdis-2017-211447⟩. ⟨hal-03879097⟩
-
Ana-Maria Orbai, Iain B. Mcinnes, Laura C. Coates, M. Elaine Husni, Dafna D. Gladman, et al.. Effect of Secukinumab on the Different GRAPPA-OMERACT Core Domains in Psoriatic Arthritis: A Pooled Analysis of 2049 Patients. Journal of Rheumatology, 2020, 47 (6), pp.854--864. ⟨10.3899/jrheum.190507⟩. ⟨hal-03879081⟩
-
Laure Gossec, Pierre Chauvin, Alain Saraux, Christophe Hudry, Gabrielle Cukierman, et al.. Development and psychometric validation of a patient-reported outcome measure to assess fears in rheumatoid arthritis and axial spondyloarthritis : the Fear Assessment in Inflammatory Rheumatic diseases (FAIR) questionnaire. Annals of the Rheumatic Diseases, 2018, 77 (2), pp.258 - 263. ⟨10.1136/annrheumdis-2017-212000⟩. ⟨hal-01795691⟩
-
Xenofon Baraliakos, Effie Pournara, Laure Gossec, Philip J Mease, Roisin White, et al.. Predictors of Response to Secukinumab in Patients with Psoriatic Arthritis and Axial Manifestations: A Post-Hoc Analysis of the MAXIMISE Trial. RMD Open : Rheumatic & Musculoskeletal Diseases, 2022, 8 (2), pp.e002303. ⟨10.1136/rmdopen-2022-002303⟩. ⟨hal-03892129⟩
-
Saskia Lawson-Tovey, Kimme Hyrich, Laure Gossec, Anja Strangfeld, Loreto Carmona, et al.. SARS-CoV-2 infection after vaccination in patients with inflammatory rheumatic and musculoskeletal diseases. Annals of the Rheumatic Diseases, 2022, 81 (1), pp.145-150. ⟨10.1136/annrheumdis-2021-221217⟩. ⟨hal-03744697⟩
-
Laure Gossec, Francis Berenbaum, Pierre Chauvin, Christophe Hudry, Gabrielle Cukierman, et al.. Correction to: Development and Application of a Questionnaire to Assess Patient Beliefs in Rheumatoid Arthritis and Axial Spondyloarthritis. Clinical Rheumatology, 2018, 37 (10), pp.2659--2659. ⟨10.1007/s10067-018-4241-9⟩. ⟨hal-03888124⟩
-
Ricardo J. O. Ferreira, Paco M. J. Welsing, Johannes W. G. Jacobs, Laure Gossec, Mwidimi Ndosi, et al.. Reexamining Remission Definitions in Rheumatoid Arthritis: Considering the 28-joint Disease Activity Score, C-reactive Protein Level, and Patient Global Assessment: Comment on the Article by Felson et Al. Arthritis Care & Research = Arthritis Care and Research, 2022, 74 (3), pp.501--502. ⟨10.1002/acr.24843⟩. ⟨hal-03849944⟩
-
Anna Molto, Laure Gossec, Bhowmik Meghnathi, Robert B M Landewé, Désirée van Der Heijde, et al.. An Assessment in SpondyloArthritis International Society (ASAS)-Endorsed Definition of Clinically Important Worsening in Axial Spondyloarthritis Based on ASDAS. Annals of the Rheumatic Diseases, 2018, 77 (1), pp.124--127. ⟨10.1136/annrheumdis-2017-212178⟩. ⟨hal-03896068⟩